What is the catalog number for PKC epsilon Rabbit Monoclonal Antibody?

The catalog number for PKC epsilon Rabbit Monoclonal Antibody is orb547632.

What sizes are available for PKC epsilon Rabbit Monoclonal Antibody?

PKC epsilon Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is PKC epsilon Rabbit Monoclonal Antibody in stock?

PKC epsilon Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

PKC epsilon Rabbit Monoclonal Antibody

Product Specifications

Product Name Alternative

NF-kappa-B inhibitor alpha; I-kappa-B-alpha; IkB-alpha; IkappaBalpha; Major histocompatibility complex enhancer-binding protein MAD3; NFKBIA; IKBA, MAD3, NFKBI

UniProt

Q02156

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human PKC epsilon This is calcium-independent, phospholipid-dependent, serine- and threonine-specific enzyme. PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters.

Target

Protein kinase C epsilon type

Clonality

Monoclonal

Clone

BCEFCX38

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Protein Biochemistry, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-2000 IHC 1:50-200 ICC/IF 1:50-200 FC 1:50

Form

Liquid

Molecular Weight

102 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.